Symbiosis II LLC lists multiple CLNN stock sales

Symbiosis II LLC reports multiple open-market sales of Common stock of CLNN recorded on Form 144.

Accepted by SEC EDGAR 05/04/2026 - 04:02 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Symbiosis II LLC reports multiple open-market sales of Common stock of CLNN recorded on Form 144. The filing lists numerous cash transactions from 01/28/2026 through 05/04/2026, including lots such as 67,991 shares on 03/31/2026 and 31,624 shares on 05/04/2026.

Key Figures

Sale on 03/31/2026: 67,991 shares Sale on 05/04/2026: 31,624 shares Sale on 04/21/2026: 61,345 shares +2 more

5 metrics

Sale on 03/31/2026 67,991 shares reported sale on 03/31/2026 with proceeds $332,103.67

Sale on 05/04/2026 31,624 shares reported sale on 05/04/2026 with proceeds $225,156.71

Sale on 04/21/2026 61,345 shares reported sale on 04/21/2026 with proceeds $376,718.05

Sale on 04/02/2026 24,925 shares reported sale on 04/02/2026 with proceeds $119,855.20

Sale on 03/27/2026 17,470 shares reported sale on 03/27/2026 with proceeds $82,908.17

Key Terms

Open Market Purchase, Common, Cash

3 terms

Open Market Purchase market

"Common | 09/30/2024 | Open Market Purchase | Issuer"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Common market

"Common | Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104"

Cash other

"09/30/2024 | Open Market Purchase | Issuer | | | 297066 | 09/30/2024 | Cash"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CLNN Form 144 filed by Symbiosis II LLC show?

It lists open-market cash sales of Common stock by Symbiosis II LLC. The filing itemizes individual trades by date, share count, and cash proceeds between 01/28/2026 and 05/04/2026, including several large lots.

How many shares were sold on CLNN on 03/31/2026?

The filing reports 67,991 shares sold on 03/31/2026. That line shows the sale and the associated cash proceeds of $332,103.67 for that lot as disclosed in the filing.

What size sale is reported on CLNN for 05/04/2026?

The filing shows a 31,624-share sale on 05/04/2026. That transaction is recorded with cash proceeds of $225,156.71 in the itemized sales listed in the filing.

Are the transactions in the filing described as open-market or private?

The filing identifies the trades as "Open Market Purchase" method and records cash as the consideration. Each itemized line includes a trade date, share count, and cash proceeds indicating public market transactions.

Who is the reporting seller in the CLNN Form 144?

The reported selling entity is Symbiosis II LLC. The filing lists that entity's address and the sequence of Common stock sales across the listed dates and amounts in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002006045
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clene Inc
SEC File Number
Address of Issuer	6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UTAH 84121
Phone	8016769695
Name of Person for Whose Account the Securities are To Be Sold	Symbiosis II LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Board Member

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	41260	270381	11778307	05/04/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2024	Open Market Purchase	Issuer			297066	09/30/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/28/2026	8717	42789.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	3810	15843.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	11474	50113.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/30/2026	5686	23493.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	2050	8262.02
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	1750	7102.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/03/2026	5559	22818.28
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/24/2026	5492	31722.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/25/2026	7098	39045.14
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/26/2026	5319	28705.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/27/2026	17470	82908.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/30/2026	15536	79283.66
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/31/2026	67991	332103.67
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/01/2026	4278	21254.31
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/02/2026	24925	119855.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/15/2026	6374	41300.6
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/16/2026	7748	49555.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/17/2026	25040	161097.44
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/20/2026	4318	26423.1
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/21/2026	61345	376718.05
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/28/2026	1591	9393.22
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/29/2026	12170	68561.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/30/2026	5736	34847.35
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	05/01/2026	5795	34837.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	05/04/2026	31624	225156.71

144: Remarks and Signature

Remarks
Date of Notice	05/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Chidozie Ugwumba
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)